These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28739485)

  • 1. HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3.
    Mahendrarajah N; Borisova ME; Reichardt S; Godmann M; Sellmer A; Mahboobi S; Haitel A; Schmid K; Kenner L; Heinzel T; Beli P; Krämer OH
    Cell Signal; 2017 Nov; 39():9-17. PubMed ID: 28739485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation.
    Buchwald M; Pietschmann K; Brand P; Günther A; Mahajan NP; Heinzel T; Krämer OH
    Oncogene; 2013 Oct; 32(41):4913-20. PubMed ID: 23208506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox.
    Mahajan NP; Whang YE; Mohler JL; Earp HS
    Cancer Res; 2005 Nov; 65(22):10514-23. PubMed ID: 16288044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6.
    Galdiero M; Vitiello M; D'Isanto M; Raieta K; Galdiero E
    Cytokine; 2006 Dec; 36(5-6):218-28. PubMed ID: 17258468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
    Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
    J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells.
    Müller S; Chen Y; Ginter T; Schäfer C; Buchwald M; Schmitz LM; Klitzsch J; Schütz A; Haitel A; Schmid K; Moriggl R; Kenner L; Friedrich K; Haan C; Petersen I; Heinzel T; Krämer OH
    Oncotarget; 2014 May; 5(10):3184-96. PubMed ID: 24833526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell type-specific and tyrosine phosphorylation-independent nuclear presence of STAT1 and STAT3.
    Meyer T; Gavenis K; Vinkemeier U
    Exp Cell Res; 2002 Jan; 272(1):45-55. PubMed ID: 11740864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes.
    McWhinney CD; Hunt RA; Conrad KM; Dostal DE; Baker KM
    J Mol Cell Cardiol; 1997 Sep; 29(9):2513-24. PubMed ID: 9299374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors induce proteolysis of activated CDC42-associated kinase-1 in leukemic cells.
    Mahendrarajah N; Paulus R; Krämer OH
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2263-73. PubMed ID: 27576506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.
    Huang JS; Guh JY; Hung WC; Yang ML; Lai YH; Chen HC; Chuang LY
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):231-8. PubMed ID: 10432321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of unphosphorylated STAT3 core fragment.
    Ren Z; Mao X; Mertens C; Krishnaraj R; Qin J; Mandal PK; Romanowski MJ; McMurray JS; Chen X
    Biochem Biophys Res Commun; 2008 Sep; 374(1):1-5. PubMed ID: 18433722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha.
    Yu CR; Lin JX; Fink DW; Akira S; Bloom ET; Yamauchi A
    J Immunol; 1996 Jul; 157(1):126-37. PubMed ID: 8683106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGF-induced apoptosis in A431 cells is dependent on STAT1, but not on STAT3.
    Grudinkin PS; Zenin VV; Kropotov AV; Dorosh VN; Nikolsky NN
    Eur J Cell Biol; 2007 Oct; 86(10):591-603. PubMed ID: 17646016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of STAT3 in head and neck cancer requires p38 MAPKinase, whereas phosphorylation of STAT1 occurs via a different signaling pathway.
    Riebe C; Pries R; Schroeder KN; Wollenberg B
    Anticancer Res; 2011 Nov; 31(11):3819-25. PubMed ID: 22110204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes.
    Krejci P; Salazar L; Goodridge HS; Kashiwada TA; Schibler MJ; Jelinkova P; Thompson LM; Wilcox WR
    J Cell Sci; 2008 Feb; 121(Pt 3):272-81. PubMed ID: 18198189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
    Shen X; Tian Z; Holtzman MJ; Gao B
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia.
    Przanowski P; Dabrowski M; Ellert-Miklaszewska A; Kloss M; Mieczkowski J; Kaza B; Ronowicz A; Hu F; Piotrowski A; Kettenmann H; Komorowski J; Kaminska B
    J Mol Med (Berl); 2014 Mar; 92(3):239-54. PubMed ID: 24097101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis.
    De Wilde K; Martens A; Lambrecht S; Jacques P; Drennan MB; Debusschere K; Govindarajan S; Coudenys J; Verheugen E; Windels F; Catrysse L; Lories R; McGonagle D; Beyaert R; van Loo G; Elewaut D
    Ann Rheum Dis; 2017 Mar; 76(3):585-592. PubMed ID: 27551052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
    Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.